Перевести на Переведено сервисом «Яндекс.Перевод»

BioAlliance Pharma

Country
France
Краткое название
BioAlliance Pharma
Headquarters
49 boulevard du G
Members of the board

Judith Greciet, Chief Executive Officer
Pierre Attali, MD, MSc, Chief Operating Officer, Strategy & Medical Affairs
Nicolas Fellmann, Vice President, Chief Financial Officer
Michel Forest, Vice President Quality, Qualified Person
Louis Kayitalire, MD, Vice President, Head of Research & Development
Aude Michel, Vice President, Licensing & Legal Affairs
Caroline Lemarchand, Preclinical R&D Director
Delphine Lucas, Regulatory Affairs Director
Sonia Vivier des Vallons, Quality Assurance Director

Categories medicine
Oncology, Infectious diseases
Stage of the project
Production
Disease
Viral hepatitis, Lung cancer
Ticker
BIO
Current owners

Patrick Langlois, Chairman of the Board of Directors
Judith Greciet, PharmD, CEO
Michel Arie
Remi Droller, Permanent Representative of Kurma Life Science Partners
Catherine Dunand
Thomas Hofstaetter
David Horn Solomon, MD
Nicolas Trebouta, MD, Permanent Representative of Financiere de la Montagne

Assets
4.3400
Technology
Cell Technologies, Devices, Technologies, Pharmaceuticals, Chemistry